Tradestie Institutional Equity Comparison Engine
MTNB vs PFE โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PFE Overall Edge
PFE Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pfizer Inc. (PFE) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MTNB trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus PFE at 9.3x Forward P/E and 29.1% operating margin (-0.4% YoY). In options structure, MTNB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PFE sits in CONSOLIDATION (28th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
PFE
MTNB N/M vs PFE 9.3x Fwd P/E
Growth & Margin Winner
PFE
Op Margin 0.0% vs 29.1% ยท YoY -100.0% vs -0.4%
Momentum & Technical Winner
PFE
1Y -31.4% vs +8.2% ยท 52W Pos 22% vs 50%
Options & Structure Winner
PFE
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (28th %ile IV)
MTNB
NYSE American
Matinas BioPharma Holdings, Inc.
Pharmaceutical Preparations
$0.81
-10.98% 1D
Market Cap
$979,904
1M Return
-46.7%
1Y Return
-31.35%
Forward P/E
N/M
Unified AI Score
54.6 / 100
HOLD
Tech 53.0
Fund 58.0
Flow 50.0
Mom 60.0
PFE
NYSE
Pfizer Inc.
Pharmaceutical Preparations
$27.54
-1.85% 1D
Market Cap
$159.9B
1M Return
-7.74%
1Y Return
+8.21%
Forward P/E
9.3x
Unified AI Score
50.2 / 100
HOLD
Tech 32.0
Fund 52.0
Flow 69.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MTNB -31.35%
PFE +8.21%
Spread: +39.56 pp (PFE Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | MTNB Revenue | PFE Revenue | MTNB Op. Margin | PFE Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $0M | $40.8B | -12230.9% | 27.3% | PFE |
| FY2019 | $0M | $40.9B | -21067.4% | 39.2% | PFE |
| FY2020 | $0M | $41.6B | -15288.4% | 22.0% | PFE |
| FY2021 | $0M | $73.6B | -74954.5% | 29.8% | PFE |
| FY2022 | $0M | $91.8B | -771.3% | 34.2% | PFE |
| FY2023 | $0M | $50.9B | -2168.4% | 4.2% | PFE |
| FY2024 | N/A | $63.6B | N/A | 12.6% | PFE |
| FY2025 | N/A | $62.6B | N/A | 12.4% | PFE |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MTNB | PFE | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $979,904 | $159.9B | Larger Scale | PFE |
| Trailing P/E Ratio Valuation | N/M | 40.1x | Lower Multiple | PFE |
| Forward P/E Ratio Valuation | N/M | 9.3x | Lower Multiple | PFE |
| Revenue Growth (YoY) Growth | -100.0% | -0.4% | Higher Growth | PFE |
| Operating Margin (TTM) Profitability | 0.0% | 29.1% | Higher Margin | PFE |
| Net Profit Margin Profitability | 0.0% | 6.3% | Higher Margin | PFE |
| Return on Equity (ROE) Capital Efficiency | -147.5% | 4.5% | Higher ROE | PFE |
| 52-Week Range Position Momentum | 22% ($0โ$3) | 50% ($24โ$31) | Stronger Trend | PFE |
| Beta / 30D Volatility Risk Regime | -7.20ฮฒ ยท 147% Vol | 0.19ฮฒ ยท 24% Vol | Lower Realized Risk | PFE |
| Unified Institutional Score Composite Signal | 54.6 / 100 (HOLD) | 50.2 / 100 (HOLD) | Higher Composite | MTNB |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MTNB vs PFE Buy Guide
MTNB
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
PFE
CONSOLIDATION
55d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
28th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MTNB nor PFE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.